E-LIB Suche - Ergebnisse für: Duffin, K Callis

1

Response to ustekinumab in a patient with both severe psori..:

Winchester, D ; Duffin, K Callis ; Hansen, C
Lupus. 21 (2012) 9 - p. 1007-1010 , 2012

Link: https://doi.org/10.1177/..

2

Secukinumab Provides Complete or Almost-Complete Psoriasis ..:

Blauvelt, A ; Armstrong, A ; Rich, P...
SKIN The Journal of Cutaneous Medicine. 2 (2018) - p. S19 , 2018

Link: https://doi.org/10.25251..

3

Efficacy and safety of ixekizumab in a randomized, double-b..:

Ryan, C. ; Menter, A. ; Guenther, L....
British Journal of Dermatology. 179 (2018) 4 - p. 844-852 , 2018

Link: https://doi.org/10.1111/..

4

Ixekizumab efficacy and safety in moderate-to-severe genita..:

Ryan, C. ; Menter, A. ; Guenther, L....
British Journal of Dermatology. 179 (2018) 4 - p. e177-e177 , 2018

Link: https://doi.org/10.1111/..

5

伊赛珠单抗在中度至重度生殖器银屑病中的疗效和安全性:

Ryan, C. ; Menter, A. ; Guenther, L....
British Journal of Dermatology. 179 (2018) 4 - p. e189-e189 , 2018

Link: https://doi.org/10.1111/..

6

Extension of ustekinumab maintenance dosing interval in mod..:

Blauvelt, A. ; Ferris, L.K. ; Yamauchi, P.S....
British Journal of Dermatology. 177 (2017) 6 - p. 1552-1561 , 2017

Link: https://doi.org/10.1111/..

7

Phase 3, open‐label, randomized study of the pharmacokineti..:

Callis Duffin, K. ; Bagel, J. ; Bukhalo, M....
Journal of the European Academy of Dermatology and Venereology. 31 (2016) 1 - p. 107-113 , 2016

Link: https://doi.org/10.1111/..

8

Onset of psoriatic arthritis during ustekinumab treatment f..:

Jones, B.B. ; Millsop, J.W. ; Walsh, J.A...
British Journal of Dermatology. 173 (2015) 1 - p. 272-274 , 2015

Link: https://doi.org/10.1111/..

9

Patient satisfaction with treatments for moderate-to-severe..:

Callis Duffin, K. ; Yeung, H. ; Takeshita, J....
British Journal of Dermatology. 170 (2014) 3 - p. 672-680 , 2014

Link: https://doi.org/10.1111/..

10

Patient Satisfaction with Treatments for Moderate-to-Severe..:

Duffin, K. Callis ; Yeung, H ; Takeshita, J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

11

43364 Long Term Real-World Patient-Reported Outcomes with R..:

Strober, Bruce E. ; Ferris, Laura K. ; Duffin, Kristina Callis...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB189 , 2023

Link: https://doi.org/10.1016/..

12

44047 Long Term Real-World Treat-to-Target Skin Clearance a..:

Armstrong, April W. ; Ferris, Laura K. ; Duffin, Kristina Callis...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB62 , 2023

Link: https://doi.org/10.1016/..

13

34820 Real-world treat-to-target skin clearance with risank..:

Armstrong, April W. ; Ferris, Laura K. ; Duffin, Kristina Callis...
Journal of the American Academy of Dermatology. 87 (2022) 3 - p. AB200 , 2022

Link: https://doi.org/10.1016/..

14

34940 Real-world patient-reported outcomes with risankizuma..:

Strober, Bruce ; Ferris, Laura K. ; Duffin, Kristina Callis
Journal of the American Academy of Dermatology. 87 (2022) 3 - p. AB101 , 2022

Link: https://doi.org/10.1016/..

15

Patient-reported outcomes of adalimumab, phototherapy, and ..:

Noe, Megan H. ; Wan, Marilyn T. ; Shin, Daniel B....
Journal of the American Academy of Dermatology. 81 (2019) 4 - p. 923-930 , 2019

Link: https://doi.org/10.1016/..